Diaceutics to attend Stifel and LSE 'Best of British' Conference in NYC
Belfast and London, 30 November 2023 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharmaceutical and biotech industry, announces that management will attend the Stifel 5th Annual 'Best of British' Discovery Conference at the London Stock Exchange's NYC offices on 13 December 2023.
Enquiries:
|
Diaceutics PLC |
|
|
Peter Keeling, Chief Executive Officer |
Tel: +44 (0)28 9040 6500 |
|
Ryan Keeling, Chief Executive Officer Designate |
investorrelations@diaceutics.com |
|
Nick Roberts, Chief Financial Officer |
|
|
Stifel Nicolaus Europe Limited (Nomad & Broker) |
Tel: +44 (0)20 7710 7600 |
|
Ben Maddison |
|
|
Nick Harland |
|
|
Kate Hanshaw |
|
|
Alma Strategic Communications |
Tel: +44(0)20 3405 0205 |
|
Caroline Forde |
diaceutics@almastrategic.com |
|
Matthew Young |
|
|
Kinvara Verdon |
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®